<Disease><Name>ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1</Name><Synonym>PORD; P450 OXIREDUCTASE DEFICIENCY</Synonym><OMIM><Number>201750</Number><URL>http://omim.org/entry/201750</URL></OMIM><Orphanet><Number>63269</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=63269</URL></Orphanet><Protein><Number>NADPH--cytochrome P450 reductase</Number><URL>http://www.uniprot.org/uniprot/P16435</URL></Protein><ExPASy><Number>1.6.2.4</Number><URL>http://enzyme.expasy.org/EC/1.6.2.4</URL></ExPASy><Gene>7q11.23</Gene><ICD>---</ICD><Summary>very rare ;autosomal recessive ;Individuals with an Antley-Bixler Syndrome (ABS)-like phenotype ... and ambiguous genitalia and disordered steroidogenesis should be recognized as having a distinct new disease: POR deficiency [Huang N et al. 2005]</Summary><Symptoms><symtomp><id>2435</id><symptom>adrenal insufficiency</symptom><category>ENDOCRINE SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3061</id><symptom>arachnodyctyly / arachnodactyly</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2208</id><symptom>clitoral hypertrophy</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3803</id><symptom>craniostenosis</symptom><category>HEAD</category></symtomp><symtomp><id>2221</id><symptom>cryptorchism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2319</id><symptom>genitalia, ambigous</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2619</id><symptom>hydronephrosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2270</id><symptom>hypertelorism</symptom><category>EYES</category></symtomp><symtomp><id>2320</id><symptom>hypospadia</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2228</id><symptom>micropenis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3341</id><symptom>oligohydramnion (maternal)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3236</id><symptom>polycystic ovaries</symptom><category>ENDOCRINE SYSTEM | GENITOURINARY TRACT</category></symtomp><symtomp><id>3335</id><symptom>scoliosis</symptom><category>BODY | SKELETAL DEFECT</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>1788</id><symptom>small mid-face (malar or maxillary hypoplasia)</symptom><category>HEAD</category></symtomp><symtomp><id>2318</id><symptom>virilisation</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2146</id><name>17-Hydoxypregnenolone [+]</name><specimen>blood</specimen><value /><min>70.00</min><max>130.00</max><unit>%</unit><age /><method /><comment /></metabolite><metabolite><id>446</id><name>17-Hydroxyprogesterone</name><specimen>plasma</specimen><value>normal/inc</value><min>1.00</min><max>93.00</max><unit>ng/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>751</id><name>17-Hydroxyprogesterone</name><specimen>plasma</specimen><value>normal/inc</value><min>50.00</min><max>1800.00</max><unit>&#181;g/dl</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>1108</id><name>17-Hydoxypregnenolone [+]</name><specimen>plasma</specimen><value>normal/inc</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>473</id><name>Adrenocorticotropic hormone (ACTH)</name><specimen>plasma</specimen><value>normal/inc</value><min>10.00</min><max>20.00</max><unit>pg/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1195</id><name>Adrenocorticotropic hormone (ACTH)</name><specimen>plasma</specimen><value>normal/inc</value><min>4.40</min><max>22.20</max><unit>pmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1110</id><name>Androstenedione</name><specimen>plasma</specimen><value /><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7395</id><title>Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the firs</title><author>Fan L,</author><journal>Orphanet J Rare Dis</journal><year>2019</year><book /><volume>14</volume><number>1</number><pages>299</pages><co_aut>et al.</co_aut></literature><literature><id>4881</id><title>P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms</title><author>Burkhard FZ,</author><journal>J Steroid Biochem Mol Biol</journal><year>2017</year><book /><volume>165</volume><number>0</number><pages>38-50</pages><co_aut>et al.</co_aut></literature><literature><id>4882</id><title>Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review</title><author>Bai Y,</author><journal>J Ovarian Res</journal><year>2017</year><book /><volume>10</volume><number>1</number><pages>16</pages><co_aut>et al.</co_aut></literature><literature><id>5042</id><title>Cytochrome P450 Oxidoreductase Deficiency</title><author>Idkowiak J,</author><journal>GeneReviews&#174; [Internet]</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5043</id><title>Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review</title><author>Bai Y,</author><journal>J Ovarian Res</journal><year>2017</year><book /><volume>10</volume><number>1</number><pages>16</pages><co_aut>Li J, Wang X</co_aut></literature><literature><id>5045</id><title>Multidisciplinary Treatment of Antley-Bixler Syndrome</title><author>Solem RC,</author><journal>Cleft Palate Craniofac J</journal><year>2017</year><book /><volume>54</volume><number>1</number><pages>100-108</pages><co_aut>et al.</co_aut></literature><literature><id>5044</id><title>Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Ph</title><author>McCammon KM;</author><journal>J Biol Chem</journal><year>2016</year><book /><volume>291</volume><number>39</number><pages>20487-502</pages><co_aut>et al.</co_aut></literature><literature><id>5046</id><title>Prenatal Diagnosis of Antley-Bixler Syndrome and POR Deficiency</title><author>Oldani E,</author><journal>Am J Case Rep</journal><year>2015</year><book /><volume>16</volume><number>0</number><pages>882-885</pages><co_aut>et al.</co_aut></literature><literature><id>4883</id><title>Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects</title><author>Fukami M,</author><journal>Pediatr Int</journal><year>2014</year><book /><volume>56</volume><number>6</number><pages>805-808</pages><co_aut>Ogata T</co_aut></literature><literature><id>5041</id><title>Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14alpha-demethylase (Cyp51) resembles Antley-Bixler syndrome</title><author>Keber R,</author><journal>J Biol Chem</journal><year>2011</year><book /><volume>286</volume><number>33</number><pages>29086-97</pages><co_aut>et al.</co_aut></literature><literature><id>2677</id><title>Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aroma</title><author>Fukami M</author><journal>Pediatr Res</journal><year>2006</year><book /><volume>59</volume><number>2</number><pages>276-280</pages><co_aut>et al.</co_aut></literature><literature><id>2678</id><title>P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia</title><author>Fluck CE</author><journal>Curr Opin Pediatr</journal><year>2006</year><book /><volume>18</volume><number>4</number><pages>435-441</pages><co_aut>Miller WL</co_aut></literature><literature><id>2679</id><title>Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency</title><author>Williamson L</author><journal>Am J Med Genet A</journal><year>2006</year><book /><volume>140</volume><number>17</number><pages>1797-1803</pages><co_aut>et al.</co_aut></literature><literature><id>2682</id><title>Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to di</title><author>Homma K</author><journal>J Clin Endocrinol Metab</journal><year>2006</year><book /><volume>91</volume><number>7</number><pages>2643-2649</pages><co_aut>et al.</co_aut></literature><literature><id>2676</id><title>P450 oxidoreductase deficiency: a new disorder of steroidogenesis</title><author>Miller WL</author><journal>Ann N Y Acad Sci</journal><year>2005</year><book /><volume>1061</volume><number>0</number><pages>100-108</pages><co_aut>et al.</co_aut></literature><literature><id>2680</id><title>Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study</title><author>Arlt W</author><journal>Lancet</journal><year>2004</year><book /><volume>363</volume><number>0</number><pages>2128-2135</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>